Anifrolumab (Saphnelo) listed in MB

March 10, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Manitoba effective April 1, 2024. For more information, please visit https://www.gov.mb.ca/health/mdbif/docs/bulletins/bulletin131.pdf

Anifrolumab (Saphnelo) listed in NS

March 6, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Nova Scotia effective March 1, 2024. The public notice and listing criteria will appear on the Nova Scotia Pharmacare Programs website when the March Bulletin is...

Let’s Talk Lupus with Jodie Young

Lupus Canada is pleased to present Let’s Talk Lupus with Jodie Young. Let’s Talk Lupus with Jodie Young December 2023 – Communication and Stress Navigating the holiday season can be exhilarating, but it often introduces a heightened level of stress into our...